top of page
Updates from the Team


SeneX Therapeutics announces an exclusive license agreement with the Icahn School of Medicine at Mount Sinai
SeneX Therapeutics, a clinical-stage biopharmaceutical company, developing disruptive gene therapies for inflammatory and age-related...
drputter
Jul 18, 20242 min read


Investing in Tomorrow: SeneX's Groundbreaking Research
Gene therapy is a groundbreaking field that has the potential to revolutionize the treatment of various diseases. One company at the...
drputter
Jun 7, 20241 min read


Revolutionizing Biotech: SeneX's Innovative Gene Therapy
Gene therapy is at the forefront of revolutionizing biotechnology, offering promising solutions for a wide range of medical conditions....
drputter
Jun 7, 20242 min read


Unlocking Potential: SeneX Gene Therapy Breakthroughs
In the realm of gene therapy breakthroughs, one company is making significant strides towards unlocking the potential of treating various...
drputter
Jun 7, 20242 min read
bottom of page
